The University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.
Dr Neena Kalia, Reader at the Institute of Cardiovascular Sciences, has been awarded a three-year BHF research grant to find out what damage diabetes does to the smallest blood vessels of the heart.
A new £850k collaboration between Birmingham Health Partners and global biotechnology leaders Roche is set to improve both diagnosis and care of patients with inflammatory bowel disease.
A major study led by the University of Birmingham has revealed that a lack of available specialist consultants in hospitals at the weekend is not the cause of the so-called 'weekend effect'.
Birmingham researchers partnered with Cancer Research UK in one of the first target identification projects for the Immuno-oncology Alliance, which translates discovery science into new therapeutics for cancer patients.